CellWell record HH-149624
Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors
Vaishali Padhye; Jui Ho
2026
In plain language
Immune checkpoint inhibitors and tyrosine kinase inhibitors frequently cause hypothyroidism as the most common endocrine adverse event, requiring routine monitoring and grade-dependent management.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-149624
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.